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RESUM
Aquesta breu revisió vol analitzar quinze anys de recerca que han portat a proposar el factor
de creixement transformant beta (TGF-β) com un component endogen auto/paracrí de la regu-
lació de les funcions diferenciades de teixits endocrins, com el còrtex adrenal. El TGF-β reuneix
els criteris requerits per aquesta funció, és a dir: a) El pèptid TGF-β està produït per les cèll. ules
adrenocorticals i expressat in situ en aquest teixit; b) el TGF-β reprimeix considerablement la
capacitat esteroidogènica d’aquestes cèll. ules reprimint els marcadors clau de diferenciació; c)
l’hormona sistèmica ACTH modula la resposta de les cèll. ules adrenocorticals al TGF-β; d) la
supressió de la síntesi de TGF-β suprimeix la inhibició de l’activitat esteroidogènica d’aquestes
cèll. ules. El sistema del TGF-β adrenocortical és, al nostre entendre, el primer circuit regulador
(loop) clarament establert en un teixit endocrí. Aquest viatge històric és un tribut al nostre amic
José Sáez, que va participar activament en el coneixement d’aquesta història.Paraules clau: còrtex adrenocortical, TGF-β, funcions diferenciades, regulació autocrina.
SUMMARY
This brief review is intended as a flash-back spanning over fifteen years of research and finally
leading to the proposal that TGF-β could be an endogenous, auto/paracrine component in the
regulation of the differentiated functions of an endocrine tissue, i.e., the adrenal cortex. TGF-β
meets the criteria required for such a function: (i) the peptide is produced by adrenocortical
cells and expressed in the tissue in situ; (ii) TGF-β strikingly down-regulates the steroidogenic
capacity of these cells by repressing key differentiation markers; (iii) the systemic hormone
ACTH modulates the adrenocortical cells’ responsiveness to TGF-β, and (iv) the suppression
of TGF-β synthesis releases the inhibition of the steroidogenic activity of these cells. The TGF-β
adrenocortical cell system was, to our knowledge, the first autocrine regulatory loop clearly
established in an endocrine tissue. This chronological account is a tribute to our friend, José
Sáez, who actively contributed to this history.
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By the mid-eighties, the pituitary peptide
adrenocorticotrophic hormone (ACTH) had
been recognized for decades as the physi-
ological agent controlling both the trophic-
ity and the differentiated steroidogenic func-
tions of the mammalian adrenal cortex in a
positive way (Simpson and Waterman, 1988;
Miller, 1988; Stocco and Clark, 1996). Corti-
costeroid secretion by adrenocortical cells is
the product of a cascade of highly specific
enzymatic reactions, starting with the side
chain cleavage of cholesterol after its import
into mitochondria and followed by a series of
cytochrome P-450 supported hydroxylations
(17α, 11β, 21, . . .). A limiting step of the path-
way is considered to be the access of choles-
terol to the inner mitochondrial membrane,
which involves the Steroidogenic Acute Regu-
latory protein (StAR) and is acutely activated
by ACTH through a cyclic AMP-protein ki-
nase A signaling. At the same time, ACTH
induces a long-term increase in the expres-
sion of the genes encoding the major steps
of the steroidogenic cascade, such as steroid
17α hydroxylase (CYP17α) and the ACTH re-
ceptor itself (Le Roy et al., 2000). In addition,
at least in adrenocortical cells of bovine ori-
gin, angiotensin II (A-II) is an acute activator
of steroidogenesis, although through a differ-
ent intracellular signaling. By the early 90s,
Fibroblast Growth Factor (FGF-2) had been
shown to induce adrenocortical cell prolif-
eration (Feige and Baird, 1991). In a search
for new possible regulators of adrenal cortex
trophicity, we presented the recently identi-
fied peptide TGF-β to bovine adrenocortical
cells.
The name TGF (Transforming Growth Fac-
tor) came from the discovery that conditioned
medium from virally transformed cells could
induce normal cells to express a transformed
phenotype, presenting the idea that a ma-
jor player in the oncogenic process had been
identified. It was soon shown that this biolog-
ical effect was due to the combination of two
active peptides: TGF-α acting as a growth fac-
tor and TGF-β which appeared, in fact, as an
inhibitor of epithelial cell proliferation (Sporn
and Roberts, 1992).
Twenty years later, TGF-β is still a mis-
leading name. While the peptide has been
established as the archetype for a large family
of multifunctional cytokines of great impor-
tance in the development and differentiation
processes (Peralta-Zaragoza et al., 2001), TGF-
β has been found to act on many normal
cellular processes. To our knowledge, TGF-β
was the first peptide to meet the criteria of an
auto/paracrine regulator of an endocrine tis-
sue, i.e., a locally produced factor, regulating
the actions of systemic hormones on their spe-
cific cellular targets.
This short review will cover 15 years of
progress establishing TGF-β as a plausible au-
tocrine regulator of adrenocortical functions.
Following this line of investigation, our re-
search Unit was accompanied by José Sáez’s
group in a constructive and stimulating com-
petition, which was always respectful and
which reinforced a warm and friendly rela-
tionship.
TGF-β IS A HIGHLY POTENT
REPRESSOR OF ADRENOCORTICAL
STEROIDOGENIC DIFFERENTIATED
FUNCTIONS
Somewhat to our surprise, no effect at all
was observed on serum or FGF supported
DNA synthesis and proliferation, when TGF-
β was added to bovine adrenocortical cells
in cultures. In contrast, the addition of TGF-
β rapidly resulted in a striking reduction in
the steroidogenic capacity of the preparation
(Feige et al., 1986).
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Basal, as well as ACTH and A-II activated
cortisol production were inhibited in a time
and dose-dependent fashion by TGF-β at pico-
molar concentrations. The effect was maximal
after 12-15 hours and resulted in an aver-
age 50% cut in the response to ACTH and
90% in the response to A-II. Detailed study
of the steroidogenic pathway pointed to 17α
hydroxylase as a major target of this negative
effect (Feige et al., 1987; Perrin et al., 1990). In-
deed, the cell contents in P-45017αmRNA and
protein were strikingly reduced following 24
hours of TGF-β treatment, in agreement with a
parallel loss of 17α hydroxylase activity. In ad-
dition, the number of cell surface receptors to
A-IIwas cut by half, explaining why TGF-β re-
duced the response toA-II more strongly than
the steroidogenic response to ACTH (Feige et
al., 1987).
After spending one year in our group, a
post-doctoral fellow (W. Rainey) joined José
Sáez’s laboratory and extended these seminal
observations to adrenocortical cells of ovine
origin, in which P-45017α was also shown to
be a major target down-regulated by TGF-β
(Rainey et al., 1990). In these species, TGF-
β reduced the expression of ACTH receptors
and blocked their up-regulation by ACTH it-
self (Rainey et al., 1989). It was also found
that TGF-β-treated cells exhibited an impaired
ability to use cholesterol for steroidogenesis.
This point was later confirmed in bovine cells
and could be explained by the fact that TGF-β
repressed the expression of the StAR protein
(Brand et al., 1998a). The negative effect of
TGF-β on steroidogenic functions was there-
after reported with normal, as well as tumoral
adrenocortical cells of human origin, although
it appeared that the specific down-regulated
molecular targets varied somewhat in differ-
ent species (Lebrethon et al., 1994).
ADRENOCORTICAL CELLS EXHIBIT
HIGH AFFINITY TGF-β RECEPTORS,
WHICH ARE REGULATED BY ACTH
Since extra-cellularly added TGF-β was ac-
tive, we searched for the presence of spe-
cific receptors at the surface of the adreno-
cortical cells. Two different TGF-β binding
systems were characterized, of higher (Kd
10–10 M) and lower (Kd 10–8 M) affinities re-
spectively. A most striking phenomenon was
that a 24 hour ACTH treatment of these cells
markedly increased (average two times) the
number of high affinity receptors (Cochet et
al., 1988). More recently, the specific intracel-
lular TGF-β signaling system, involving Smad
proteins, was demonstrated in bovine adreno-
cortical cells, confirming their status as TGF-β
target cells (Brand et al., 1998).
These observations strongly suggested that
ACTH exposure should result in the in-
creased sensitivity of adrenocortical cells to
the inhibitory action of TGF-β giving a basis
for a negative regulatory feed-back control,
limiting the positive actions of ACTH itself
(Feige et al., 1991; Langlois et al., 1998).
TGF-β IS PRODUCED
BY ADRENOCORTICAL CELLS,
SUGGESTING ITS PARTICIPATION
IN AN AUTOCRINE
REGULATORY LOOP
Immunohistochemistry clearly established
that TGF-β was expressed in bovine adreno-
cortical tissue, especially in the fasciculata-
reticularis layers, corresponding to active
steroidogenic zones (Keramidas et al., 1991).
Using a specific assay, biosynthesis and se-
cretion of the peptide was unambiguously
demonstrated. TGF-β mRNA appeared con-
stitutively expressed in bovine adrenocortical
cells, and a production of about 5 ng of pep-
tide/24 hours/106 cells could be assessed un-
der basal culture conditions. This could result
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in local concentrations well in the range of the
functionally effective ones (see above).
When the molecular form of TGF-β se-
creted by the adrenocortical cells was exam-
ined in detail, it became clear that the peptide
was not under a free moiety, as already re-
ported from other biological sources (Savona
et al., 1994; Bailly et al., 1997). Adrenocortical
TGF-β appeared to be included in two ma-
jor polypeptide complexes. One contained the
Latent TGF-β Binding Protein (LTBP), known
to be a major combination in blood platelets.
The other was identified as a complex with α2-
macroglobulin (α2-M), known to be a blood
protein able to trap a number of cytokines
(Feige et al., 1996). However, TGF-β com-
plexed with α2-M appeared to be active when
added to adrenocortical cells (Keramidas et al.,
1992).
Together with α2-M, it was discovered that
adrenocortical cells secrete another protein,
whose production was greatly stimulated
by ACTH. This corticotrophin-induced se-
creted protein was finally identified as throm-
bospondin 2 (TSP-2) (Pellerin et al., 1993).
Most interestingly, TSP-2 was shown to ac-
tivate TGF-β when the peptide was com-
plexed with LTBP (Souchelnitskiy et al., 1995).
In addition to ACTH, TGF-β itself appeared
to stimulate adrenocortical TSP-2 secretion
(Negoescu et al., 1995), thus, contributing to
an extra-cellular environment, which would
favor the occurrence of biologically potent
TGF-β.
TGF-β AND THE ADRENOCORTICAL
CELLS: THE AUTO/PARACRINE
MODEL
All the accumulated observations strongly
suggested that endogenously produced TGF-
β could be acting as a regulator of adreno-
cortical cell-differentiated functions, serving
as a local relay in balance with the systemic
hormone ACTH. TGF-β could represent an in
situ negative feed-back control loop, opposing
most of the effects of ACTH. ACTH, in turn,
could be controlling cell responsiveness to the
peptide (Chambaz et al., 1996).
The validity of this working hypothesis was
definitively confirmed by José Saez’s group,
using an anti-sense oligonucleotide approach,
which targeted the expression of TGF-β in
bovine adrenocortical cells (Le Roy et al.,
1996). Conveniently chosen anti-sense was
shown to enter the cells and to markedly in-
hibit TGF-β mRNA expression and peptide
synthesis. Under these conditions, a large in-
crease (×2) in the steroidogenic capacity of
the cells, in response to an ACTH challenge,
was observed, parallel to a similar increase
in the expression of cyt P45017α hydroxy-
lase. This clearly showed that the neutraliza-
tion of the endogenous TGF-β signal resulted
in the suppression (release) of a pathway,
negatively regulating the steroidogenic dif-
ferentiated functions in these cells. Thus, in
this system TGF-β most likely represented an
endogenous (autocrine) regulator, integrated
as a negative local loop in the action of
ACTH.
CONCLUSION
After more than fifteen years of experi-
mental observation, TGF-βmay be considered
an autocrine regulator of adrenocortical cell-
differentiated functions for solid reasons:
— Adrenocortical cells produce and secrete
TGF-β which is present in the tissue in situ.
— These cells express TGF-β receptors and
the corresponding specific intracellular sig-
naling.
— TGF-β acts as a repressor of differen-
tiated steroidogenic adrenocortical functions
by negatively regulating the expression of
specific cellular targets. TGF-β globally op-
poses the positive effects of ACTH on the
same targets.
—ACTH controls the local TGF-β loop, e.g.,
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by up-regulating the TGF-β receptors, thus,
initiating the limitation of its own action.
— The suppression of TGF-β local produc-
tion results in an amplification of the ACTH-
effects, in agreement with a release of the local
brake represented by the peptide. This last
point convincingly establishes TGF-β as an in
situ component in adrenocortical functions.
Using a similar approach, it was suggested
that TGF-β contributed to an autocrine neg-
ative loop opposing the action of the trophic
hormones LH/HCG in Leydig cells (Le Roy
et al., 1999). Knock-out of the TGF-β1 gene
in mice resulted in the early death of new-
borns with severe inflammatory syndrome.
However, no targeted invalidation of the gene
has yet been reported in endocrine tissue that
could possibly support the autocrine model.
In addition to TGF-β a number of peptides
have been shown to be produced by adreno-
cortical cells and may represent local relays
in ACTH action, although they are not in-
cluded in the local regulatory loop (Penhoat
et al., 1996; Feige et al., 1998). This is the case
with FGF-2, IGF-1 and IGF-2, possible relays
for the trophic action of ACTH. One should
point out that, as seen with TGF-β, these pep-
tides are complexed in the extra-cellular mi-
lieu with binding proteins or proteoglycans.
Thus, an additional mechanism of fine regula-
tion may take place at that level, leading to the
concept of crinopexy (Feige and Baird, 1995).
In addition to control of the differentiated
steroidogenic functions of endocrine adreno-
cortical cells, locally produced factors may be
crucial to the coordinated control of the very
important vasculature of the gland. Such a
paracrine role is clearly suggested for Vascu-
lar Endothelial Growth Factor (V-EGF), which
is produced by endocrine adrenocortical cells
and is the most powerful growth and differen-
tiation factor for endothelial cells and angio-
genesis (Thomas et al., 2003, 2004). The role of
locally produced TGF-β in combination with
V-EGF in this process remains to be clarified.
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